HVA

DRUG2 trials

Sponsors

Nanfang Hospital, Southern Medical University, Guangdong Second Provincial General Hospital

Conditions

Newly Diagnosed Acute Myeloid Leukemia With High RiskNewly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)

Phase 2

HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).

Enrolling by invitationNCT07517510

Guangdong Second Provincial General HospitalNewly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)

Start: 2026-04-01End: 2027-12-31Target: 40Updated: 2026-04-08

Phase 3

HVA vs IA/DA or VA in the Treatment of ND HR-AML

RecruitingNCT06810791

Nanfang Hospital, Southern Medical UniversityNewly Diagnosed Acute Myeloid Leukemia With High Risk

Start: 2025-01-01End: 2026-12-31Target: 876Updated: 2025-02-06